Skip to main content

9 January 2024 - Future cancer - Oral evidence

Committee Health and Social Care Committee
Inquiry Future cancer

Tuesday 9 January 2024

Start times: 9:30am (private) 10:00am (public)

Add to calendar

Can clinical innovation improve outcomes for least survivable cancers?

MPs consider the extent to which innovation can improve outcomes for some of the least survivable cancers, including pancreatic cancer, brain cancer, and some respiratory cancers. This fifth session in the future cancer inquiry looks at innovations capable of improving poor rates in early diagnosis and lead to increased life expectancy. Treatment and funding for research into less survivable cancers are expected to be examined, along with the impact of existing health inequalities.

Meeting details

At 9:30am: Private discussion
Inquiry Future cancer
At 10:00am: Oral evidence
Inquiry Future cancer
Consultant Respiratory Physician and Honorary Professor of Medicine at School of Medicine (University of Nottingham)
Co-Lead of Precision-Panc, and Chair of Surgical Oncology at University of Glasgow
Honorary Associate Professor and Consultant in medical oncology at University College London and University College London Hospitals
At 10:45am: Oral evidence
Inquiry Future cancer
Executive Vice President and Chief Medical Officer at American Society of Clinical Oncology
Board Member (European Cancer Organisation), and Associate Pro-Vice-Chancellor and Professor of Digital Health at Queen's Univeristy Belfast

The session also considers what the UK can learn from international cancer strategies in the EU and the USA. Research and opportunities for international collaboration are likely to be raised.

The Committee is examining innovations with the greatest potential to transform cancer diagnosis and treatment for patients in the short, medium and long term, and how they can best be transitioned into frontline clinical settings.


Room 6, Palace of Westminster

How to attend